![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Press Release: NEJM publishes ALTUVIIIO XTEND-Kids phase 3 data supporting its potential to transform the treatment landscape for children with severe hemophilia A NEJM publishes ALTUVIIIO...
Communiqué de presse : Le NEJM publie les données de phase III de l’étude XTEND-Kids montrant qu’ALTUVIIIO a le potentiel de transformer la prise en charge thérapeutique des enfants atteints...
Communiqué de presse : Dupixent devient le tout premier médicament ciblé pour le traitement de la BPCO approuvé dans l’Union européenne Dupixent devient le tout premier médicament ciblé pour...
Press Release: Dupixent positive phase 3 data in children one to 11 years of age with eosinophilic esophagitis published in NEJM Dupixent positive phase 3 data in children one to 11 years of...
Communiqué de presse : Mise en ligne du document « Aide-mémoire Q2 2024 » Mise en ligne du document « Aide-mémoire Q2 2024 » Paris, France, le 25 juin 2024. Sanofi annonce la mise en ligne...
Press Release: Audrey Duval Derveloy appointed Global Head of Corporate Affairs, member of Sanofi’s Executive Committee Audrey Duval Derveloy appointed Global Head of Corporate Affairs...
Press Release: ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and fitusiran ISTH: Sanofi advances leadership in hemophilia with new data for ALTUVIIIO and...
Communiqué de presse : Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique Sanofi et Biovac pionniers de la production de vaccins contre la polio en Afrique...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.04 | -0.0426393774651 | 93.81 | 94.17 | 90.86 | 875 | 91.95454857 | DE |
4 | 5.76 | 6.54471082831 | 88.01 | 94.85 | 88 | 1151 | 92.09931153 | DE |
12 | 1.41 | 1.52663490689 | 92.36 | 94.85 | 86.2 | 969 | 90.98859394 | DE |
26 | 0.16 | 0.170921910052 | 93.61 | 94.85 | 84.98 | 870 | 89.90251837 | DE |
52 | -5.23 | -5.28282828283 | 99 | 104.22 | 80.75 | 814 | 90.0310654 | DE |
156 | 6.89 | 7.93047882136 | 86.88 | 106.06 | 76.36 | 1081 | 89.97876448 | DE |
260 | 19.14 | 25.646522846 | 74.63 | 106.06 | 68 | 1552 | 86.98939613 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions